Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,987 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
High performance imaging streak camera for the National Ignition Facility.
Opachich YP, Kalantar DH, MacPhee AG, Holder JP, Kimbrough JR, Bell PM, Bradley DK, Hatch B, Brienza-Larsen G, Brown C, Brown CG, Browning D, Charest M, Dewald EL, Griffin M, Guidry B, Haugh MJ, Hicks DG, Homoelle D, Lee JJ, Mackinnon AJ, Mead A, Palmer N, Perfect BH, Ross JS, Silbernagel C, Landen O. Opachich YP, et al. Among authors: griffin m. Rev Sci Instrum. 2012 Dec;83(12):125105. doi: 10.1063/1.4769753. Rev Sci Instrum. 2012. PMID: 23278024
Dietary Iron Fortification Did Not Affect the Intestinal Microbiome for Channel Catfish (Ictalurus punctatus) Juveniles, but Decreased Their Resistance Against Edwardsiella ictaluri.
Yamamoto FY, Older CE, Khoo LH, Romano N, Richardson BM, Ott BD, Wise DJ, Ware C, Goodman PM, Reifers JG, Griffin MJ. Yamamoto FY, et al. Among authors: griffin mj. J Fish Dis. 2024 Dec 10:e14060. doi: 10.1111/jfd.14060. Online ahead of print. J Fish Dis. 2024. PMID: 39655747 No abstract available.
A potent and selective reaction hijacking inhibitor of Plasmodium falciparum tyrosine tRNA synthetase exhibits single dose oral efficacy in vivo.
Xie SC, Tai CW, Morton CJ, Ma L, Huang SC, Wittlin S, Du Y, Hu Y, Dogovski C, Salimimarand M, Griffin R, England D, de la Cruz E, Deni I, Yeo T, Burkhard AY, Striepen J, Schindler KA, Crespo B, Gamo FJ, Khandokar Y, Hutton CA, Rabie T, Birkholtz LM, Famodimu MT, Delves MJ, Bolsher J, Koolen KMJ, van der Laak R, Aguiar ACC, Pereira DB, Guido RVC, Creek DJ, Fidock DA, Dick LR, Brand SL, Gould AE, Langston S, Griffin MDW, Tilley L. Xie SC, et al. Among authors: griffin mdw. PLoS Pathog. 2024 Dec 9;20(12):e1012429. doi: 10.1371/journal.ppat.1012429. Online ahead of print. PLoS Pathog. 2024. PMID: 39652589 Free article.
Terminal complement inhibition and control of hemolysis in patients with paroxysmal nocturnal hemoglobinuria who switched from high-dose eculizumab to ravulizumab: a phase IV, single-arm clinical trial.
Griffin M, Gandhi S, Kelly RJ, Munir T, Trikha R, Hicks E, Jain D, Ogawa M, Yu J, Muus P, Kulasekararaj AG. Griffin M, et al. Haematologica. 2024 Nov 28. doi: 10.3324/haematol.2024.285553. Online ahead of print. Haematologica. 2024. PMID: 39605209 Free article.
2,987 results